The devices have surged in popularity among people without diabetes, but a study suggests reality may not match the hype.

Kihealth’s diabetes assay, which measures the earliest biomarker of insulin resistance, is claimed to be the first diagnostic of its kind.

Wearable devices and biometric tracking can alert clinicians to early warning signs conditions, allowing interventions before hospitalisation becomes necessary ...

Home blood sugar testing has become efficient and nearly painless with the use of modern devices. Regular monitoring, guided by physicians, helps mana ...

Continuous glucose monitors (CGMs) are wearable technologies that track blood sugar in real time and help patients with type 2 diabetes improve blood sugar control. In 2024, the U.S. Food and Drug ...

The lateral flow assay market is poised for growth via increasing home-based self-testing kits, integration with smartphones for telehealth, and expansions in food safety and environmental monitoring.

The draft EASD/ADA Type 1 Diabetes Management Guidance document adds new information about diagnosing T1D in adults as well as obesity management, technology, and complications screening.

Zoey Chan invented a pocket-sized organiser to simplify daily Type 1 diabetes injections, while Gunika Jain designed a discreet self-testing kit to help rural women in India screen for human ...

A man with type 1 diabetes produces his own insulin after receiving genetically-modified donor islet cells, without the need for medication.